Patents by Inventor Alex T. Adai

Alex T. Adai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS
    Publication number: 20190017122
    Abstract: Embodiments concern methods and compositions for distinguishing benign from malignant thyroid tumor in a patient based on the expression levels of one or more miRNAs.
    Type: Application
    Filed: January 17, 2018
    Publication date: January 17, 2019
    Inventors: Sylvie Beaudenon-Huibregtse, Dennis Wylie, Alex T. Adai
  • miRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20140274791
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MiRNA biomarkers of lung disease
    Patent number: 8735074
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: May 27, 2014
    Assignee: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MIRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20110053158
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 3, 2011
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth MAMBO, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary